Moderna Withdraws FDA Application for Combo Flu-COVID Vaccine
Moderna's biologics license application for its flu/COVID combination vaccine candidate for adults aged 50 years and older.
Moderna's biologics license application for its flu/COVID combination vaccine candidate for adults aged 50 years and older.
Moderna’s biologics license application for its flu/COVID combination vaccine candidate for adults aged 50 years and older.
Read MoreAdults who were hospitalized for a severe infection, such as respiratory infections or sepsis, were more than twice as likely to develop heart failure years later.
Read MoreH5N1 avian flu has been detected in domestic cats across the United States. Are there risks of cat-to-human transmission?
Read MoreA recent CDC statement may signal a shift in the agency’s longstanding practice of advocating vaccinations for infectious diseases like measles.
Read MoreExisting H5N1 avian flu vaccines may be less effective against newer strains due to rapid viral adaptation.
Read MoreTwo FDA–approved flu antivirals did not successfully treat severe H5N1 infections, and route of infection (eye, nose or mouth) significantly impacted effectiveness.
Read MoreThe FDA convened an interagency panel to comprise its recommendations for the 2025-2026 flu vaccine composition.
Read MoreA national poll found 2-in-5 parents wish the government was doing more to prevent a bird flu outbreak.
Read MoreA portable biosensor cuts detection time for airborne H5N1 virus particles to less than five minutes — significantly faster than conventional PCR tests.
Read MoreA scheduled meeting of the US FDA’s influenza vaccine advisory board set for March 13 has been canceled, following another postponement by the CDC last week.
Read MoreVisby Medical’s handheld PCR test that differentiates between influenza A, B, and COVID-19 received FDA clearance and a CLIA waiver.
Read MoreCold and flu season is the time of year when Poison Control Centers see an increase in calls related to the overuse of acetaminophen to alleviate flu-like symptoms.
Read MoreInfluenza A viruses rapidly adjust their shape when placed in conditions that reduce infection efficiency, such as the presence of antiviral antibodies or host incompatibility.
Read MoreNational Institutes of Health (NIH) scientists and their colleagues report that a single dose of a broadly neutralizing antibody (bnAb) administered prior to virus exposure protects macaques from severe H5N1 avian influenza.
Read MoreA new antiviral modeling approach combines various experimental techniques to create a comprehensive picture of a virus’ dynamic behavior.
Read MoreAccording to a CDC update, as of February 1, 2025, influenza test positivity increased to 31.6% nationally.
Read MoreThe RNA-based vaccine showed full protection in mice against the H5N1 strain circulating in US cattle.
Read MoreMonkeys exposed to H5N1 via the mouth and stomach resulted in limited infection without clinical signs, while exposure via the nose and windpipe caused mild to severe illness.
Read MoreA Louisiana patient over the age of 65 has died after contracting H5N1 bird flu from exposure to wild and backyard birds.
Read MoreNational Institutes of Health officials have outlined four strategies for managing the H5N1 avian influenza outbreak.
Read MoreCalifornia Governor Gavin Newsom declared a State of Emergency to strengthen the state’s response to bird flu after its detection in Southern California dairy cows and its spread to 16 states.
Read MoreA patient in Louisiana has been hospitalized with a severe case of H5N1 bird flu, marking the first instance of severe illness linked to the virus in the United States, according to the CDC.
Read MoreResearchers discovered that pregnancy strengthens immune defenses, contrary to common belief, blocking the flu virus from spreading to the lungs.
Read MoreAn NIH-funded study identified a mutation in the H5N1 avian influenza virus that enhances its ability to bind to human cells.
Read More